Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

Clinical trial NCT04684524 · COMPLETED

Trial details

NCT number: NCT04684524
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Fungal Rhinosinusitis

Start date: 2020-12-01
Primary completion: 2024-12-14
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.